PLoS ONE · 2011 · 36 citations · 34 references
We present a cell based system and experimental approach to characterize agonist and antagonist selectivity for ligand-gated ion channels (LGIC) by developing sensor cells stably expressing a Ca(2+) permeable LGIC and a genetically encoded Förster (or fluorescence) resonance energy transfer (FRET)-based calcium sensor. In particular, we describe separate lines with human α7 and human α4β2 nicotinic acetylcholine receptors, mouse 5-HT(3A) serotonin receptors and a chimera of human α7/mouse 5-HT(3A) receptors. Complete concentration-response curves for agonists and Schild plots of antagonists were generated from these sensors and the results validate known pharmacology of the receptors tested. Concentration-response relations can be generated from either the initial rate or maximal amplitudes of FRET-signal. Although assaying at a medium throughput level, this pharmacological fluorescence detection technique employs a clonal line for stability and has versatility for screening laboratory generated congeners as agonists or antagonists on multiple subtypes of ligand-gated ion channels. The clonal sensor lines are also compatible with in vivo usage to measure indirectly receptor activation by endogenous neurotransmitters.
34
The 5-HT3B subunit is a major determinant of serotonin-receptor function
Paul Davies, Marco Pistis, Michael C. Hanna et al. · Nature · 1999 · 559 citations
Neurotransmitter, Receptor (Biochemistry), Molecular Biology +9
Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
Robert Freedman, Ann Olincy, Robert W. Buchanan et al. · American Journal of Psychiatry · 2008 · 421 citations · Full text